{"id":"https://openalex.org/W2099228076","doi":"https://doi.org/10.1097/00001504-200101000-00004","title":"Comorbid conditions in schizophrenia","display_name":"Comorbid conditions in schizophrenia","alternate_titles":[],"publication_year":2001,"publication_date":"2001-01-01","ids":{"openalex":"https://openalex.org/W2099228076","doi":"https://doi.org/10.1097/00001504-200101000-00004","mag":"2099228076"},"language":"en","primary_location":{"id":"doi:10.1097/00001504-200101000-00004","doi":"https://doi.org/10.1097/00001504-200101000-00004","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00001504-200101000-00004","pdf_url":null,"source":{"id":"https://openalex.org/S15258550","display_name":"Current Opinion in Psychiatry","issn_l":"0951-7367","issn":["0951-7367","1473-6578"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in Psychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2099228076"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111859982","display_name":"Wayne S. Fenton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Wayne S. Fenton","raw_affiliation_strings":["Division of Mental Disorders, Behavioral Research, and AIDS, National Institute of Mental Health, Bethesda, Maryland, USA","SCID: structured clinical interview for DSM IV","SSRI: selective serotonin reuptake inhibitor","to Wayne S. Fenton, MD, Deputy Director for Clinical Affairs, Division of Mental Disorders, Behavioral Research, and AIDS, National Institute of Mental Health, 6001 Executive Boulevard, MSC 9621, Bethesda, MA 20892, USA. Tel: +1 301 443 9700; fax: +1 301 443 6000; e-mail: [email\u00a0protected]","e-mail: [email\u00a0protected]","fax: +1 301 443 6000","to Wayne S. Fenton, MD, Deputy Director for Clinical Affairs, Division of Mental Disorders, Behavioral Research, and AIDS, National Institute of Mental Health, 6001 Executive Boulevard, MSC 9621, Bethesda, MA 20892, USA. Tel: +1 301 443 9700"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Mental Disorders, Behavioral Research, and AIDS, National Institute of Mental Health, Bethesda, Maryland, USA","institution_ids":["https://openalex.org/I4210158500"]},{"raw_affiliation_string":"SCID: structured clinical interview for DSM IV","institution_ids":[]},{"raw_affiliation_string":"SSRI: selective serotonin reuptake inhibitor","institution_ids":[]},{"raw_affiliation_string":"to Wayne S. Fenton, MD, Deputy Director for Clinical Affairs, Division of Mental Disorders, Behavioral Research, and AIDS, National Institute of Mental Health, 6001 Executive Boulevard, MSC 9621, Bethesda, MA 20892, USA. Tel: +1 301 443 9700; fax: +1 301 443 6000; e-mail: [email\u00a0protected]","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210158500"]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: +1 301 443 6000","institution_ids":[]},{"raw_affiliation_string":"to Wayne S. Fenton, MD, Deputy Director for Clinical Affairs, Division of Mental Disorders, Behavioral Research, and AIDS, National Institute of Mental Health, 6001 Executive Boulevard, MSC 9621, Bethesda, MA 20892, USA. Tel: +1 301 443 9700","institution_ids":["https://openalex.org/I4210158500"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5111859982"],"corresponding_institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210158500"],"apc_list":null,"apc_paid":null,"fwci":0.8574,"has_fulltext":false,"cited_by_count":50,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.71318567,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"14","issue":"1","first_page":"17","last_page":"23"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12308","display_name":"Mental Health and Psychiatry","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1211","display_name":"Philosophy"},"field":{"id":"https://openalex.org/fields/12","display_name":"Arts and Humanities"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9800000190734863},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.7580000162124634},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.7080000042915344},{"id":"https://openalex.org/keywords/obsessive-compulsive-disorder","display_name":"obsessive-compulsive disorder","score":0.9990000128746033},{"id":"https://openalex.org/keywords/panic-disorder","display_name":"panic disorder","score":0.9769999980926514},{"id":"https://openalex.org/keywords/substance-use-disorders","display_name":"substance use disorders","score":0.9929999709129333},{"id":"https://openalex.org/keywords/suicide-risk","display_name":"suicide risk","score":0.8180000185966492},{"id":"https://openalex.org/keywords/long-term-disability","display_name":"long-term disability","score":0.8579999804496765},{"id":"https://openalex.org/keywords/medication-non-adherence","display_name":"medication non-adherence","score":0.9819999933242798},{"id":"https://openalex.org/keywords/hospitalization","display_name":"hospitalization","score":0.906000018119812},{"id":"https://openalex.org/keywords/antipsychotic-induced-weight-gain","display_name":"antipsychotic-induced weight gain","score":0.8159999847412109},{"id":"https://openalex.org/keywords/glucose-and-lipid-metabolism","display_name":"glycolipid metabolism","score":0.7070000171661377},{"id":"https://openalex.org/keywords/metabolic-comorbidities","display_name":"metabolic comorbidities","score":0.6200000047683716}],"concepts":[{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.7431966066360474},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.7070099711418152},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.660860538482666},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.6097588539123535},{"id":"https://openalex.org/C2777529043","wikidata":"https://www.wikidata.org/wiki/Q741713","display_name":"Panic disorder","level":3,"score":0.5843251347541809},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.5826654434204102},{"id":"https://openalex.org/C2780712732","wikidata":"https://www.wikidata.org/wiki/Q208450","display_name":"Panic","level":3,"score":0.5369923114776611},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5151532888412476},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.47861140966415405},{"id":"https://openalex.org/C27415008","wikidata":"https://www.wikidata.org/wiki/Q7256382","display_name":"Psychological intervention","level":2,"score":0.4756752550601959},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.11980074644088745},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1097/00001504-200101000-00004","doi":"https://doi.org/10.1097/00001504-200101000-00004","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00001504-200101000-00004","pdf_url":null,"source":{"id":"https://openalex.org/S15258550","display_name":"Current Opinion in Psychiatry","issn_l":"0951-7367","issn":["0951-7367","1473-6578"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in Psychiatry","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":48,"referenced_works":["https://openalex.org/W56162586","https://openalex.org/W1786776278","https://openalex.org/W1843161899","https://openalex.org/W1924228574","https://openalex.org/W1964522439","https://openalex.org/W1964538442","https://openalex.org/W1973107264","https://openalex.org/W1976314897","https://openalex.org/W1977544418","https://openalex.org/W1980733422","https://openalex.org/W1986491654","https://openalex.org/W1989974319","https://openalex.org/W1998554429","https://openalex.org/W1999320625","https://openalex.org/W2001686560","https://openalex.org/W2007865301","https://openalex.org/W2010407707","https://openalex.org/W2019341028","https://openalex.org/W2022847093","https://openalex.org/W2038991788","https://openalex.org/W2040936438","https://openalex.org/W2044926400","https://openalex.org/W2046346817","https://openalex.org/W2049550440","https://openalex.org/W2066839548","https://openalex.org/W2080399940","https://openalex.org/W2080877504","https://openalex.org/W2089671853","https://openalex.org/W2102123079","https://openalex.org/W2104135276","https://openalex.org/W2108327356","https://openalex.org/W2111105929","https://openalex.org/W2120324643","https://openalex.org/W2120510232","https://openalex.org/W2128155179","https://openalex.org/W2133434159","https://openalex.org/W2139376256","https://openalex.org/W2140251161","https://openalex.org/W2144481847","https://openalex.org/W2145252524","https://openalex.org/W2146118647","https://openalex.org/W2154080026","https://openalex.org/W2162222189","https://openalex.org/W2166504150","https://openalex.org/W2169269570","https://openalex.org/W2232669364","https://openalex.org/W2325983999","https://openalex.org/W4297040264"],"related_works":["https://openalex.org/W2130638685","https://openalex.org/W4254061947","https://openalex.org/W2155945003","https://openalex.org/W193217575","https://openalex.org/W55642590","https://openalex.org/W2901781491","https://openalex.org/W2232059920","https://openalex.org/W2081099269","https://openalex.org/W2051148580","https://openalex.org/W2730622613"],"abstract_inverted_index":{"Psychiatric":[0],"syndromes,":[1],"including":[2],"depression,":[3],"obsessive-compulsive":[4],"disorder,":[5],"panic,":[6],"and":[7,27,41,54,64,71,75,91],"substance":[8],"use":[9],"disorders,":[10],"co-occur":[11],"with":[12,20,31,87],"schizophrenia":[13,21],"at":[14],"significant":[15,81],"rates.":[16],"These":[17],"syndromes":[18,50],"interact":[19],"symptoms":[22],"in":[23,84],"clinically":[24],"meaningful":[25],"ways,":[26],"can":[28],"be":[29],"associated":[30],"adverse":[32],"outcomes":[33],"such":[34],"as":[35,80],"suicide,":[36],"long-term":[37],"disability,":[38],"medication":[39],"nonadherence,":[40],"frequent":[42],"hospitalization.":[43],"Data":[44],"to":[45,59],"inform":[46],"treatment":[47,67],"of":[48,66,73],"co-occurring":[49],"are":[51,57,78,94],"largely":[52],"anecdotal,":[53],"further":[55],"studies":[56],"required":[58],"understand":[60],"better":[61],"the":[62],"risks":[63],"benefits":[65],"options.":[68],"Weight":[69],"gain":[70],"disturbances":[72],"glucose":[74],"lipid":[76],"metabolism":[77],"emerging":[79],"medical":[82],"comorbidities":[83],"patients":[85],"treated":[86],"new-generation":[88],"antipsychotic":[89],"agents,":[90],"preventive":[92],"interventions":[93],"urgently":[95],"needed.":[96]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2099228076","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
